Get the Stockscreener App
20.77
1.66%
0.34
City Therapeutics, Inc. Common Stock stock is traded at $20.77, with a volume of 127.60K.
It is up +1.66% in the last 24 hours and up +0.00% over the past month.
See More
Previous Close:
$20.43
Open:
$20.62
24h Volume:
127.60K
Relative Volume:
0.38
Market Cap:
$1.05B
Revenue:
Net Income/Loss:
P/E Ratio:
-
EPS:
-
Net Cash Flow:
1W Performance:
+0.00%
1M Performance:
+0.00%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$19.75
$22.00
52-Week Range:
$19.75
$22.00
City Therapeutics, Inc. Common Stock Stock (CTY) Company Profile
Name
City Therapeutics, Inc. Common Stock
Sector
Industry
Phone
-
Address
-
Compare CTY vs VRTX, REGN, MRNA, ARGX, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CTY
City Therapeutics, Inc. Common Stock
|
20.77 | 1.05B | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
523.93 | 132.80B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
805.02 | 82.88B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
200.10 | 79.89B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
873.71 | 54.94B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
377.63 | 42.72B | 5.76B | 514.49M | 1.10B | 4.4813 |
City Therapeutics, Inc. Common Stock Stock (CTY) Latest News
City Therapeutics Director Ron M Philip Awarded 22,649-Share Stock Option - Kalkine Media
ARCH Venture Fund XII Converts Preferred Shares to Common Stock at City Therapeutics IPO - Kalkine Media
City Therapeutics closes $230 million upsized IPO By Investing.com - Investing.com South Africa
At its IPO close, City Therapeutics (CTY) saw ARCH buy 170,000 shares and convert preferred stock. - Stock Titan
At the IPO closing, ARCH bought 170,000 City Therapeutics (CTY) shares at $18 each. - Stock Titan
IPO conversion gives City Therapeutics (CTY) director John Maraganore 610,759 common shares. - Stock Titan
Director receives 22,649 stock options with an $18 exercise price at City Therapeutics (CTY). - Stock Titan
IPO closing fully vests 77,979 CEO options at City Therapeutics (CTY). - Stock Titan
A director receives 22,649 City Therapeutics (CTY) options with an $18 exercise price. - Stock Titan
Barry E. Greene acquires an option on 22,649 City Therapeutics (CTY) shares with an $18 exercise price. - Stock Titan
City Therapeutics closes $230 million upsized IPO By Investing.com - Investing.com Canada
A company developing medicines that silence genes brought in about $230 million before costs. - Stock Titan
City Therapeutics Announces Closing of $230.0 Million Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares - Yahoo Finance Singapore
City Therapeutics Announces Closing of $230.0 Million Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares - GlobeNewswire
City Therapeutics, Inc. (CTY) Company Information - Simply Wall Street
City Therapeutics (CTY) director Barry E. Greene holds an option to buy 59,878 shares at $0.92 each. - Stock Titan
A director’s City Therapeutics (CTY) holdings include an option for 135,611 shares at $5.36. - Stock Titan
Director Ron M. Philip holds a $0.92 option on 59,878 City Therapeutics (CTY) shares - Stock Titan
Medical chief holds options with $1.84 and $5.36 exercise prices at City Therapeutics (CTY). - Stock Titan
CEO holds 1.06M shares in City Therapeutics (CTY), plus options priced at $0.92 and $5.36. - Stock Titan
Holdings in City Therapeutics (CTY) include 2.72M common shares and convertible preferred stock. - Stock Titan
Director Sara Nochur holds an option on 59,878 City Therapeutics (CTY) shares at a $0.92 exercise price. - Stock Titan
City Therapeutics prices IPO at $18 per share, raising $200M - Investing.com
A stock sale is expected to bring City Therapeutics about $200 million. - Stock Titan
City Therapeutics (CTY) COO holds 534,511 shares plus options exercisable at $0.92 and $5.36. - Stock Titan
City Therapeutics, Inc. Common Stock Stock (CTY) Financials Data
There is no financial data for City Therapeutics, Inc. Common Stock (CTY). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
City Therapeutics, Inc. Common Stock Stock (CTY) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| NELSEN ROBERT | Director |
Oct 19 '26 |
Buy |
18.00 |
170,000 |
3,060,000 |
13,692,507 |
9.38%
0.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):